journal article·2024-04

Anti‐Inflammatory Peptide‐Conjugated Silk Fibroin/Cryogel Hybrid Dual Fiber Scaffold with Hierarchical Structure Promotes Healing of Chronic Wounds

Ruyi Fan, Jiebing Zhao, Lei Yi, Jiayi Yuan, Alec McCarthy, Bo Li, Ganghua Yang, Johnson V. John, Wenbing Wan, Yi Zhang, Shixuan Chen

Advanced Materials· Volume 36· Issue 16
Publisher page

Abstract

Abstract Chronic wounds resulting from diabetes, pressure, radiation therapy, and other factors continue to pose significant challenges in wound healing. To address this, this study introduces a novel hybrid fibroin fibrous scaffold (FFS) comprising randomly arranged fibroin fibers and vertically aligned cryogel fibers (CFs). The fibroin scaffold is efficiently degummed at room temperature and simultaneously formed a porous structure. The aligned CFs are produced via directional freeze‐drying, achieved by controlling solution concentration and freezing polymerization temperature. The incorporation of aligned CFs into the expanded fibroin fiber scaffold leads to enhanced cell infiltration both in vitro and in vivo, further elevating the hybrid scaffold's tissue compatibility. The anti‐inflammatory peptide 1 (AP‐1) is also conjugated to the hybrid fibrous scaffold, effectively transforming the inflammatory status of chronic wounds from pro‐inflammatory to pro‐reparative. Consequently, the FFS‐AP1+CF group demonstrates superior granulation tissue formation, angiogenesis, collagen deposition, and re‐epithelialization during the proliferative phase compared to the commercial product PELNAC. Moreover, the FFS‐AP1+CF group displays epidermis thickness, number of regenerated hair follicles, and collagen density closer to normal skin tissue. These findings highlight the potential of random fibroin fibers/aligned CFs hybrid fibrous scaffold as a promising approach for skin tissue filling and tissue regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Silk-based biomaterials and applications · Electrospun Nanofibers in Biomedical Applications · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Burn and Plastic Surgery Affiliated Hospital of Nantong University Nantong 226001 China

Zhejiang Engineering Research Center for Tissue Repair Materials Wenzhou Institute University of the Chinese Academy of Sciences Wenzhou Zhejiang 325000 China

Department of Orthopedics Shanghai Pudong Hospital Fudan University Pudong Medical Center Shanghai 201399 China

Department of Burn Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

Department of Surgery‐Transplant and Mary and Dick Holland Regenerative Medicine Program University of Nebraska Medical Center Omaha NE 68198 USA

Department of Orthopaedic Surgery the Second Affiliated Hospital Jiangxi Medical College Nanchang University Nanchang Jiangxi 330006 China

Terasaki Institute for Biomedical Innovation Los Angeles CA 90064 USA

Funding

National Natural Science Foundation of China · Chinese Academy of Sciences · Health Commission of Jiangxi Province

References (37)

Show source-provided references
1. 10.1039/C4SM01772B10.1039/C4SM01772B ↗
2. 10.1002/adma.20200375410.1002/adma.202003754 ↗
3. 10.1126/sciadv.abg308910.1126/sciadv.abg3089 ↗
4. 10.1021/acs.nanolett.9b0021710.1021/acs.nanolett.9b00217 ↗
5. 10.1016/j.progpolymsci.2007.05.01310.1016/j.progpolymsci.2007.05.013 ↗
6. 10.1016/j.actbio.2019.11.05010.1016/j.actbio.2019.11.050 ↗
7. 10.1002/adhm.20200053010.1002/adhm.202000530 ↗
8. 10.1016/j.jconrel.2022.11.01910.1016/j.jconrel.2022.11.019 ↗
9. 10.1016/j.progpolymsci.2013.09.00210.1016/j.progpolymsci.2013.09.002 ↗
10. 10.1002/adma.20200016510.1002/adma.202000165 ↗
11. 10.1016/j.jclepro.2020.12108010.1016/j.jclepro.2020.121080 ↗
12. 10.1002/app.2649210.1002/app.26492 ↗
13. 10.1016/j.biortech.2010.05.10010.1016/j.biortech.2010.05.100 ↗
14. 10.1016/j.msec.2017.06.01510.1016/j.msec.2017.06.015 ↗
15. Lo C.‐H. · J. Mater. Sci. Chem. Eng. · 2017 · 5 · 1
16. 10.1016/j.jare.2022.12.00510.1016/j.jare.2022.12.005 ↗
17. 10.1016/j.cellbi.2008.04.02310.1016/j.cellbi.2008.04.023 ↗
18. 10.2174/156801403348372510.2174/1568014033483725 ↗
19. 10.1021/acsbiomaterials.5b0023810.1021/acsbiomaterials.5b00238 ↗
20. 10.1002/adhm.20160080810.1002/adhm.201600808 ↗
21. 10.1016/j.biomaterials.2018.06.03110.1016/j.biomaterials.2018.06.031 ↗
22. 10.1177/0734242X1140473310.1177/0734242X11404733 ↗
23. 10.1016/j.ijbiomac.2017.06.01910.1016/j.ijbiomac.2017.06.019 ↗
24. 10.1016/j.matdes.2019.10807710.1016/j.matdes.2019.108077 ↗
25. 10.1021/ma048988v10.1021/ma048988v ↗
26. 10.1002/mabi.20210029210.1002/mabi.202100292 ↗
27. 10.1039/D3TB00097D10.1039/D3TB00097D ↗
28. 10.1038/nmat148710.1038/nmat1487 ↗
29. 10.1021/acsnano.7b0196510.1021/acsnano.7b01965 ↗
30. 10.1021/acs.nanolett.9b0180510.1021/acs.nanolett.9b01805 ↗
31. 10.1038/nprot.2013.00210.1038/nprot.2013.002 ↗
32. 10.1038/s41467-020-18276-010.1038/s41467-020-18276-0 ↗
33. 10.1038/s41572-022-00377-310.1038/s41572-022-00377-3 ↗
34. 10.18632/oncotarget.2320810.18632/oncotarget.23208 ↗
35. 10.1016/j.smim.2014.05.00410.1016/j.smim.2014.05.004 ↗
36. 10.1007/s10856-019-6319-610.1007/s10856-019-6319-6 ↗
37. 10.1016/j.bioactmat.2020.12.00610.1016/j.bioactmat.2020.12.006 ↗